Our results identified that C21orf58 promoted cell cycle by accelerating G1/S phase transition and enhanced the expression of p‐STAT3, which suggested that C21orf58 might endow HCC cells with malignant growth ability by modulating the activity of STAT3 signaling. Here, STAT3 is linked to hepatocellular carcinoma.